308080.KS · 바이젠셀

South Korea · RS rating 40 · As of 2026-10-14

Price5,500.00 KRW
1-day change+0.2%
RS rating (overall / 1M / 3M / 12M)40 / 7 / 38 / 84
StageDeclining
Composite / Minervini / CANSLIM score35 / 18 / 39
Industry group (rank)Medical-Biomed/Biotech (95)
EPS growth Q/Q+9.5%
Sales growth Q/Q+73.8%
Distance from 52-week high+65.2%
Market cap (USD)$89.2M
Open South Korea in the interactive screener